Resmed

RMD · NYSE

$245.50+$5.73 (+2.39%)TodayMarket closed · Oct 20, 7:46 PM ET

Prev close $239.77

News sentiment

Tone of recent coverage

Social media sentiment, last 30 days

Average tone of posts mentioning RMD, from −1 (all negative) to +1 (all positive). Latest day: +0.00 across 66 mentions.

Latest news

Press releaseOct 19, 8:00 AM ETGlobe Newswire
Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.
NewsOct 12, 7:43 AM ET
ResMed Q4 2026 Earnings Call Transcript
NewsOct 7, 12:53 PM ETPiero Cingari
Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%
Press releaseOct 1, 4:05 PM ETGlobe Newswire
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
Press releaseAug 27, 4:15 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
Press releaseAug 27, 4:05 PM ETGlobe Newswire
Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
Press releaseAug 25, 6:33 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
Press releaseAug 25, 9:00 AM ETGlobe Newswire
23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs
Press releaseAug 17, 4:10 PM ETGlobe Newswire
Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
NewsAug 7, 8:02 AM ETAvi Kapoor
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
NewsAug 6, 4:05 PM ET
ResMed Q4 Adj. EPS $2.95 Beats $2.89 Estimate, Sales $1.464B Beat $1.459B Estimate
Press releaseAug 6, 4:05 PM ETGlobe Newswire
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
Press releaseJul 21, 4:40 PM ETPRNewswire
BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD)
NewsJul 9, 2:03 PM ETVandana Singh
ResMed Analyst Backs Portfolio Reset
NewsJul 7, 5:29 PM ET
ResMed Says Deal Valued At $490M All-Cash, Expected To Close In Q1 FY2027
Press releaseJul 7, 4:30 PM ETGlobe Newswire
Resmed Announces Agreement to Sell MatrixCare Business
Press releaseJun 30, 4:30 PM ETGlobe Newswire
Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026
Press releaseJun 3, 7:40 AM ETGlobe Newswire
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
Press releaseJun 1, 4:05 PM ETGlobe Newswire
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
Press releaseMay 19, 4:05 PM ETGlobe Newswire
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Press releaseMay 19, 9:00 AM ETGlobe Newswire
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
NewsMay 12, 7:00 AM ETTanya Rawat
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
NewsApr 30, 5:53 PM ET
Transcript: ResMed Q3 2026 Earnings Conference Call
Press releaseApr 30, 4:10 PM ETGlobe Newswire
Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
Press releaseApr 30, 4:05 PM ETGlobe Newswire
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
Press releaseApr 1, 4:05 PM ETGlobe Newswire
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
Press releaseMar 3, 3:00 AM ETGlobe Newswire
Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
Press releaseFeb 24, 9:00 AM ETGlobe Newswire
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
Press releaseJan 29, 4:05 PM ETGlobe Newswire
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
NewsJan 28, 12:01 PM ET
Earnings Preview For ResMed
Press releaseJan 8, 4:05 PM ETGlobe Newswire
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
Press releaseDec 18, 4:05 PM ETGlobe Newswire
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Press releaseDec 8, 9:00 AM ETGlobe Newswire
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
NewsNov 3, 9:23 AM ETAvi Kapoor
Nvidia To Rally Around 73%? Here Are 10 Top Analyst Forecasts For Monday
NewsOct 31, 1:26 PM ETPiero Cingari
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
NewsOct 31, 9:24 AM ETAvi Kapoor
These Analysts Revise Their Forecasts On ResMed Following Q1 Results
Press releaseOct 30, 4:05 PM ETGlobe Newswire
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
NewsSep 18, 10:00 AM ETAvi Kapoor
This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
NewsSep 18, 7:30 AM ETAvi Kapoor
This Target Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
Press releaseJul 31, 4:05 PM ETGlobe Newswire
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

News sentiment

Social media sentiment, last 30 days

Latest news

Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.

ResMed Q4 2026 Earnings Call Transcript

Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD

Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD

23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs

Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor

Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

ResMed Q4 Adj. EPS $2.95 Beats $2.89 Estimate, Sales $1.464B Beat $1.459B Estimate

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026

BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD)

ResMed Analyst Backs Portfolio Reset

ResMed Says Deal Valued At $490M All-Cash, Expected To Close In Q1 FY2027

Resmed Announces Agreement to Sell MatrixCare Business

Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio

Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'

Transcript: ResMed Q3 2026 Earnings Conference Call

Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026

Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026

Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Earnings Preview For ResMed

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

Nvidia To Rally Around 73%? Here Are 10 Top Analyst Forecasts For Monday

Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?

These Analysts Revise Their Forecasts On ResMed Following Q1 Results

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

This Target Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025